Javier, Esterlita L.
HRN: 03-08-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/27/2023
10/04/2023
IVT
600 Mg
Q8hrs
ABSCESS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes